NasdaqGS:APLSBiotechs
Apellis Cell And Gene Update Puts Growth Story In Investor Focus
Apellis Pharmaceuticals (NasdaqGS:APLS) is scheduled to present at the 2026 Cell & Gene Meeting on the Mediterranean.
The conference appearance will focus on the company’s cell and gene therapy programs.
The event is expected to draw interest from biotech specialists and investors who track emerging therapeutic platforms.
Apellis Pharmaceuticals (NasdaqGS:APLS) is known for work in complement biology, and its upcoming presence at the 2026 Cell & Gene Meeting on the Mediterranean puts a...